Antikoaguliacijos valdymas ir panaikinimas

Reversal of antithrombotic agents. (atsiveria naujas langas)

Bauer KA.

Šaltinis‎: Am J Hematol 2012;87 Suppl 1:S119-26.

Kodas‎: PubMed 22460529

DOI‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (atsiveria naujas langas)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (atsiveria naujas langas)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

Šaltinis‎: J Thromb Haemost 2015;13(10):1790-8.

Kodas‎: PubMed 26270886

DOI‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (atsiveria naujas langas)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (atsiveria naujas langas)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

Šaltinis‎: N Engl J Med 2019;380(14):1326-35.

Kodas‎: PubMed 30730782

DOI‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (atsiveria naujas langas)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (atsiveria naujas langas)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

Šaltinis‎: N Engl J Med 2016;375(12):1131-41.

Kodas‎: PubMed 27573206

DOI‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (atsiveria naujas langas)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (atsiveria naujas langas)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

Šaltinis‎: Circulation 2011;124(14):1573-9.

Kodas‎: PubMed 21900088

DOI‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (atsiveria naujas langas)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (atsiveria naujas langas)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Šaltinis‎: Lancet 2015;385(9982):2077-87.

Kodas‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (atsiveria naujas langas)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (atsiveria naujas langas)

Gordon JL, Fabian TC, Lee MD, Dugdale M

Šaltinis‎: J Trauma Acute Care Surg 2013;75(3):475-86.

Kodas‎: PubMed 24089118

DOI‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (atsiveria naujas langas)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (atsiveria naujas langas)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Šaltinis‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Kodas‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (atsiveria naujas langas)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (atsiveria naujas langas)

Levi M, Eerenberg E, Kamphuisen PW.

Šaltinis‎: J Thromb Haemost 2011;9(9):1705-12.

Kodas‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (atsiveria naujas langas)

Emergency reversal of warfarin anticoagulation. (atsiveria naujas langas)

Lin Y, Callum J.

Šaltinis‎: CMAJ 2010;182(18):2004.

Kodas‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (atsiveria naujas langas)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (atsiveria naujas langas)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Šaltinis‎: Thromb Haemost 2012;108(2):217-24.

Kodas‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (atsiveria naujas langas)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (atsiveria naujas langas)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

Šaltinis‎: J Thromb Haemost 2008;6(4):622-31.

Kodas‎: PubMed 18208533

DOI‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (atsiveria naujas langas)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (atsiveria naujas langas)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

Šaltinis‎: Blood Adv 2019;3(2):158-67.

Kodas‎: PubMed 30658963

DOI‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (atsiveria naujas langas)

Idarucizumab for dabigatran reversal. (atsiveria naujas langas)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Šaltinis‎: N Engl J Med 2015;373(6):511-20.

Kodas‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (atsiveria naujas langas)

Idarucizumab for dabigatran reversal - full cohort analysis. (atsiveria naujas langas)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Šaltinis‎: N Engl J Med 2017;377(5):431-41.

Kodas‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (atsiveria naujas langas)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (atsiveria naujas langas)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

Šaltinis‎: Blood 2003;102(13):4594-9.

Kodas‎: PubMed 12920042

DOI‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (atsiveria naujas langas)

Role of agents for reversing the effects of target-specific oral anticoagulants. (atsiveria naujas langas)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

Šaltinis‎: Am J Health Syst Pharm 2017;74(2):54-61.

Kodas‎: PubMed 27895055

DOI‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (atsiveria naujas langas)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (atsiveria naujas langas)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Šaltinis‎: Anesth Analg 2011;113(4):703-10.

Kodas‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (atsiveria naujas langas)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (atsiveria naujas langas)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

Šaltinis‎: J Am Coll Cardiol 2017;70(24):3042-67.

Kodas‎: PubMed 29203195

DOI‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (atsiveria naujas langas)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (atsiveria naujas langas)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Šaltinis‎: World Neurosurg 2014;81(1):110-5.

Kodas‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (atsiveria naujas langas)

Reversal of warfarin-induced hemorrhage in the emergency department. (atsiveria naujas langas)

Zareh M, Davis A, Henderson S.

Šaltinis‎: West J Emerg Med 2011;12(4):386-92.

Kodas‎: PubMed 22224125

DOI‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (atsiveria naujas langas)

INTENSYVIOJI IR KRITINĖ TERAPIJA

Antikoaguliacijos valdymas ir panaikinimas

lietuvių

Antikoaguliacijos valdymas ir panaikinimas

https://assetsnffrgf-a.akamaihd.net/assets/ct/46e9307b0a/images/syn_placeholder_sqr.png

Reversal of antithrombotic agents. (atsiveria naujas langas)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (atsiveria naujas langas)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (atsiveria naujas langas)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (atsiveria naujas langas)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (atsiveria naujas langas)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (atsiveria naujas langas)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (atsiveria naujas langas)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (atsiveria naujas langas)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (atsiveria naujas langas)

Emergency reversal of warfarin anticoagulation. (atsiveria naujas langas)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (atsiveria naujas langas)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (atsiveria naujas langas)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (atsiveria naujas langas)

Idarucizumab for dabigatran reversal. (atsiveria naujas langas)

Idarucizumab for dabigatran reversal - full cohort analysis. (atsiveria naujas langas)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (atsiveria naujas langas)

Role of agents for reversing the effects of target-specific oral anticoagulants. (atsiveria naujas langas)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (atsiveria naujas langas)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (atsiveria naujas langas)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (atsiveria naujas langas)

Reversal of warfarin-induced hemorrhage in the emergency department. (atsiveria naujas langas)

Susisiekite su vietiniu atstovu

Medicininės informacijos paketai

Filmai

Antikoaguliacijos valdymas ir panaikinimas

Kalbos pasirinkimas

Dalintis